WebApr 25, 2024 · About ERYTECH and GRASPA® ERYTECH is a clinical-stage biopharmaceutical company developing innovative red blood cell-based therapeutics for … WebApr 25, 2024 · ERYTECH Pharma (NASDAQ:ERYP) announced the sale of its US manufacturing facility to Catalent (NYSE:CTLT), a leading contract development and manufacturing organization in advanced therapies for a ...
ERYTECH Sells U.S. Manufacturing Facility and Enters Long-Term Suppl…
WebJan 24, 2024 · About ERYTECH: www.erytech.com ERYTECH is a clinical-stage biopharmaceutical company developing innovative red blood cell-based therapeutics for severe forms of cancer and orphan diseases. WebApr 6, 2024 · ERYTECH Pharma S.A., a clinical-stage biopharmaceutical company, develops red blood cell-based therapeutics for cancer and orphan diseases in France and the United States. Its lead product candidate is eryaspase, which is in Phase 3 clinical development for the treatment of second-line pancreatic cancer, and in Phase 2 stage for … coach cooley salary
ERYTECH Granted U.S. FDA Fast Track Designation for Eryaspase …
Weberytech is located in Lyon, Rhone-Alpes, France. Who invested in erytech? erytech has 10 investors including Armistice Capital and Bpifrance. How much funding has erytech raised to date? erytech has raised $227.5M. … WebMar 22, 2024 · Income tax expense in 2024 was €0.5 million, reflecting the expected tax impacts of the capital gain from the sale of the Princeton facility. As of December 31, 2024, ERYTECH had cash and cash equivalents totaling €38.8 million (approximately $41.5 million), compared with €33.7 million as of December 31, 2024. WebMar 31, 2024 · ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The firm conducts research and development of innovative red blood … calculator with no batteries crossword